Gelonghui April 25 | Qianhong Pharmaceutical (002550.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 461 million yuan, a year-on-year decrease of 24.19%; the net profit attributable to shareholders of the listed company was 104 million yuan, a year-on-year increase. 21.13%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 102 million yuan, a year-on-year increase of 19.11%; basic earnings per share was 0.0827 yuan.
Qianhong Pharmaceutical (002550.SZ): Net profit in the first quarter was 104 million yuan, a year-on-year increase of 21.13%
Gelonghui April 25 | Qianhong Pharmaceutical (002550.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 461 million yuan, a year-on-year decrease of 24.19%; the net profit attributable to shareholders of the listed company was 104 million yuan, a year-on-year increase. 21.13%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 102 million yuan, a year-on-year increase of 19.11%; basic earnings per share was 0.0827 yuan.
Like (0)
Not favored by dealers? Shede Liquor Industry\’s contract liabilities fell by 15.11% in the first quarter, and accounts receivable increased by nearly 50% month-on-month.
Previous
April 25, 2024 7:59 pm
The vaccine market is turbulent, and Zhifei Biotech’s “big brother” status is difficult to maintain
Next
April 25, 2024 7:59 pm